The Office of Management and Budget (OMB) has released a memorandum
to all executive department heads making major changes to the interpretation
of OMB Circular A-21, the circular that guides facilities and administrative
(F&A or indirect) cost policy. The changes concern the treatment of
voluntary faculty effort and tuition remission. The policy changes, which
OMB calls a "clarification," are a result of the four-year Office
of Science and Technology Policy-led review of the federal-academic research
partnership and President Clinton's related executive order issued Dec.
29.
OMB has announced that voluntary uncommitted faculty effort will no
longer be included in the organized research base for computing the F&A
rate or reflected in the allocation of F&A costs. In addition, such
faculty effort will now be excluded from effort reporting. The recent application
of Cost Accounting Standard to A-21 had the effect of reducing F&A
reimbursements as a result of voluntary faculty effort on federally supported
grants. This perverse outcome has been a source of significant friction
between academic institutions and federal agencies for several years.
OMB also has announced that the tuition remission costs of graduate
students charged to federal programs under the provisions of A-21 are not
contingent on there being an employer-employee relationship, for tax purposes,
between the institution and the graduate student. For several years, agencies
have interpreted A-21 to mean that, for tuition remission costs to be allowable,
students must be treated as employees of the university, for tax purposes,
which would mean that students' tuition remission benefits must be treated
as taxable wages. OMB has provided criteria under which tuition remission
and other forms of support are allowable, regardless of whether they qualify
as wages for tax purposes. OMB says the change "recognizes the reality
that research activities are an essential component of the individual's
educational activities."
Information: Tony Mazzaschi,
AAMC Division of Biomedical and Health Sciences Research, 202-828-0059.